ALTERNATIVES

The Contently alternative for Biotech & Pharma teams

DIRECT ANSWER

For Biotech & Pharma companies weighing Contently, CoMo is the autonomous-CMO alternative: it runs Biotech & Pharma marketing across every channel on your live stack, under your approval.

Biotech & Pharma marketing and Contently

The MLR bottleneck is the defining pain. Position AI-CMO as a pre-MLR content acceleration layer — draft variations auto-generated with reference tagging to approved label language, so reviewers approve faster. Integration with Veeva Vault PromoMats is table stakes for enterprise deals. Secondary angle: omnichannel orchestration for HCP journeys that synchronize rep calls, emails, and event invites without manual coordination.

Biotech & Pharma teams typically hit: Medical, Legal, Regulatory (MLR) review queues create 4–8 week delays that make campaigns stale before they launch; HCP segmentation is done manually in Excel — field reps don't have actionable, data-driven targeting for their territories; Congress season (ASCO, ADA, ACC) creates content demand spikes that small medical affairs teams cannot absorb; Patient support programs are marketed reactively rather than through proactive lifecycle journeys; KOL engagement tracking is scattered across MSL notes, CRM fields, and email threads with no unified view; Brand teams in different therapeutic areas duplicate research and creative work with no shared asset library. FDA 21 CFR Part 202 (prescription drug advertising); FDA guidance on social media and internet promotion; OPDP fair balance requirements; EFPIA Code (EU); PhRMA Code on interactions with HCPs; HIPAA for patient data; MLR approval documentation must be retained; off-label promotion prohibition is absolute

Why Biotech & Pharma teams pick CoMo

CoMo is the right choice for teams that want marketing output — content, paid campaigns, SEO, PR, lifecycle — without managing freelancer networks, editorial queues, or production workflows. CoMo's agents produce content grounded in live SEO and performance data, amplify it through paid, and measure what worked, all without a project manager in the middle. Operator plan at $399/mo vs Contently's $24K–$50K+ annual platform fee (before freelancer costs).

When Contently is the better fit: Contently is genuinely better when the content quality bar requires human expert writers — investigative journalism, deeply technical whitepapers, narrative brand stories, or highly regulated content that needs a credentialed subject-matter expert. The 160,000+ vetted freelancer network is a real asset for enterprises that measure content quality by human craft, not throughput..

FAQ

Contently alternative for Biotech & Pharma — common questions

Is CoMo a good Contently alternative for Biotech & Pharma?

For Biotech & Pharma teams that want autonomous execution across every channel on their existing stack, yes. CoMo is the right choice for teams that want marketing output — content, paid campaigns, SEO, PR, lifecycle — without managing freelancer networks, editorial queues, or production workflows. CoMo's agents produce content grounded in live SEO and performance data, amplify it through paid, and measure what worked, all without a project manager in the middle. Operator plan at $399/mo vs Contently's $24K–$50K+ annual platform fee (before freelancer costs).

BUILT BY COMO'S AGENTS

This page was written by CoMo — the autonomous CMO.

CoMo runs every channel of your marketing on your live data. See it work on your brand.

Book a live demo